# PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin

> **NCT02273908** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 331 (actual)

## Conditions studied

- Low-Back Pain

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02273908
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-02
- **Final completion:** 2015-03
- **Target enrollment:** 331 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02273908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02273908, "PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02273908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*